搜尋





搜尋





Recursion Pharmaceuticals Inc

RXRX

添加自選

3.200USD

+0.040+1.27%

收盤 09-11 16:00（美東）

1.70B總市值

虧損本益比TTM

盤後交易 18:44 (美東)3.200USD+0.010+0.31%

Recursion Pharmaceuticals Inc

3.200

+0.040+1.27%

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

RXRX 利潤表

您可以在這裡找到Recursion Pharmaceuticals Inc的年度或季度收入報告，以深入了解Recursion Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q2

營業總收入

-60.10%7.67M

-56.11%6.47M

681.74%35.54M

-80.16%5.17M

33.34%19.22M

6.89%14.74M

-58.26%4.55M

147.62%26.08M

30.86%14.42M

13.68%13.79M

-20.36%10.89M

-19.96%10.53M

43.56%11.02M

127.53%12.13M

439.91%13.68M

419.34%13.16M

201.06%7.67M

108.16%5.33M

--2.53M

1270.43%2.55M

--2.56M

--186.00K

營業收入

-60.10%7.67M

-56.11%6.47M

681.74%35.54M

-80.16%5.17M

33.34%19.22M

6.89%14.74M

-58.26%4.55M

147.62%26.08M

30.86%14.42M

13.68%13.79M

-20.36%10.89M

-19.96%10.53M

43.56%11.02M

127.53%12.13M

439.91%13.68M

419.34%13.16M

201.06%7.67M

108.16%5.33M

--2.53M

1270.43%2.55M

--2.56M

--186.00K

主營業務成本

-43.00%11.49M

-42.78%12.49M

11.58%14.28M

21.59%14.69M

119.17%20.16M

95.50%21.83M

29.48%12.79M

11.05%12.08M

-1.95%9.20M

-10.30%11.17M

-8.85%9.88M

-29.41%10.88M

-34.05%9.38M

59.61%12.45M

--10.84M

--15.41M

--14.23M

--7.80M

----

營業費用

-27.02%142.64M

-34.51%134.98M

-23.60%143.87M

42.54%177.38M

70.02%195.45M

87.15%206.11M

71.47%188.31M

13.04%124.44M

23.97%114.96M

36.31%110.13M

47.10%109.82M

45.36%110.08M

30.49%92.73M

31.78%80.80M

10.62%74.66M

54.76%75.73M

63.45%71.06M

85.54%61.31M

--67.49M

--48.94M

136.25%43.48M

--33.05M

--18.40M

研發費用

-39.43%77.91M

-41.99%75.20M

5.62%95.94M

71.72%121.06M

83.69%128.64M

102.05%129.63M

52.45%90.83M

5.84%70.50M

30.99%70.03M

37.90%64.16M

47.81%59.58M

63.41%66.61M

39.35%53.46M

43.75%46.52M

-12.36%40.31M

22.88%40.76M

29.83%38.36M

34.67%32.37M

--46.00M

--33.17M

123.10%29.55M

--24.03M

--13.24M

折舊攤銷及損耗

-23.82%18.17M

1.77%19.67M

68.92%25.84M

120.12%21.04M

165.43%23.85M

161.23%19.33M

101.28%15.30M

25.79%9.56M

60.45%8.98M

97.23%7.40M

133.77%7.60M

154.27%7.60M

101.01%5.60M

35.16%3.75M

26.20%3.25M

16.03%2.99M

12.52%2.79M

87.82%2.78M

--2.58M

147.60%2.48M

--1.48M

--1.00M

營業利潤

23.41%-134.97M

32.85%-128.50M

41.05%-108.33M

-75.08%-172.20M

-75.28%-176.23M

-98.64%-191.37M

-85.76%-183.77M

1.20%-98.35M

-23.04%-100.54M

-40.30%-96.34M

-62.23%-98.93M

-59.09%-99.55M

-28.91%-81.72M

-22.66%-68.67M

6.12%-60.98M

-34.85%-62.57M

-54.88%-63.39M

-83.64%-55.98M

---64.96M

---46.40M

-124.67%-40.93M

---30.48M

---18.22M

淨非營業利息收入（費用）

利息收入

-2.52%5.31M

7.29%5.96M

35.45%6.26M

44.46%5.54M

66.66%5.44M

37.30%5.56M

2.17%4.62M

-22.95%3.83M

-34.11%3.27M

-13.13%4.05M

22.81%4.52M

171.52%4.98M

660.28%4.96M

5256.32%4.66M

--3.68M

3566.00%1.83M

2148.28%652.00K

443.75%87.00K

----

--50.00K

20.83%29.00K

--16.00K

--24.00K

利息費用

-35.63%309.00K

-31.10%350.00K

----

48.22%833.00K

21.83%480.00K

2440.00%508.00K

2226.92%605.00K

2148.00%562.00K

1415.38%394.00K

5.26%20.00K

100.00%26.00K

92.31%25.00K

85.71%26.00K

35.71%19.00K

--13.00K

-94.09%13.00K

-99.44%14.00K

-94.38%14.00K

----

--220.00K

487.09%2.50M

--249.00K

--426.00K

特殊收入（費用）

----

--0.00

-1208.33%-15.70M

----

0.00%-1.20M

--0.00

100.00%0.00

---1.20M

--0.00

100.00%0.00

---2.80M

----

--0.00

---827.00K

----

其他非經營性收入（費用）

-63.51%-1.03M

225.04%784.00K

-805.62%-6.03M

983.00%5.25M

-61.48%-633.00K

-491.88%-627.00K

132.55%854.00K

-137.57%-594.00K

-775.86%-392.00K

255.34%160.00K

-1365.92%-2.62M

413.31%1.58M

928.57%58.00K

-45.07%-103.00K

-717.24%-179.00K

1162.07%308.00K

---7.00K

---71.00K

--29.00K

---29.00K

----

---324.00K

稅前利潤

23.79%-131.01M

39.74%-122.11M

39.57%-108.10M

-69.58%-162.25M

-75.29%-171.90M

-119.90%-202.65M

-84.32%-178.90M

-2.86%-95.67M

-27.81%-98.06M

-41.06%-92.15M

-68.82%-97.06M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

所得稅

---1.00K

-2813.92%-4.60M

185.71%20.00K

-98.20%3.00K

100.00%0.00

79.72%-158.00K

100.17%7.00K

--167.00K

---523.00K

---779.00K

---4.06M

----

除稅後利潤

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

持續經營利潤

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

歸属于母公司的淨利潤

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

歸屬普通股東的淨利潤

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

基本每股收益

40.26%-0.25

55.84%-0.22

61.03%-0.21

-7.03%-0.36

-2.27%-0.41

-29.86%-0.50

-31.70%-0.53

22.46%-0.34

-3.17%-0.40

-13.56%-0.39

-30.45%-0.40

-25.51%-0.44

-2.53%-0.39

-3.95%-0.34

19.05%-0.31

-23.84%-0.35

-21.36%-0.38

-79.71%-0.33

---0.38

---0.28

-168.52%-0.31

---0.18

---0.12

稀釋每股收益

40.26%-0.25

55.84%-0.22

61.03%-0.21

-7.03%-0.36

-2.27%-0.41

-29.86%-0.50

-31.70%-0.53

22.46%-0.34

-3.17%-0.40

-13.56%-0.39

-30.45%-0.40

-25.51%-0.44

-2.53%-0.39

-3.95%-0.34

19.05%-0.31

-23.84%-0.35

-21.36%-0.38

-79.71%-0.33

---0.38

---0.28

-168.52%-0.31

---0.18

---0.12

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Recursion Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 RXRX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Recursion Pharmaceuticals Inc 財年末的營收是多少？



Recursion Pharmaceuticals Inc 2025 財年營收為 74.68M，高於上一財年的 58.84M。

Recursion Pharmaceuticals Inc 最近一個季度的營收是多少？



Recursion Pharmaceuticals Inc 最近一個季度的營收為 7.67M，同比增長 -60.10%。

Recursion Pharmaceuticals Inc 全年的淨利潤是多少？



Recursion Pharmaceuticals Inc 2025 財年淨利潤為 -644.76M。

Recursion Pharmaceuticals Inc 上一季度的淨利潤是多少？



Recursion Pharmaceuticals Inc 最近一個季度的淨利潤為 -131.00M。

Recursion Pharmaceuticals Inc 年度營業利潤是多少？



Recursion Pharmaceuticals Inc 2025 財年的營業利潤為 -648.13M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。